Skip to content
    HSG logo

    HSG

    Hong KongFounded 2005

    HSG (formerly HongShan / Sequoia Capital China) is a leading venture capital and private equity firm founded in 2005 by Neil Shen. It invests globally across technology, healthcare, and consumer sectors, managing over USD 61 billion in assets.

    Deal activity increased 44% year-over-year (13 deals in the last 12 months). Average disclosed round size is $182.9M (across 232 rounds with reported amounts).

    Find people at HSG on Goldilocks AI

    Portfolio

    211

    Fund Size

    $2.5B

    Top Stage

    Series B

    Last 12 Mo

    13

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    316 investments
    CompanyRoundAmountDate
    它它石智航Seed$455MApr 2026
    SIGMAS logoSIGMASSeed$1MMar 2026
    Aridge logoAridgeUnknown$200MMar 2026
    DDifySeries A$30MMar 2026
    Kast logoKastSeries A$80MMar 2026
    QuantX Biosciences logoQuantX BiosciencesSeries B$85MFeb 2026
    QQuantXSeries B$85MFeb 2026
    X2Robot logoX2RobotSeries C$140MJan 2026
    Vibrant Therapeutics logoVibrant TherapeuticsSeries C$61MJan 2026
    Spiro Medical logoSpiro MedicalSeries A$67MJan 2026
    Clipto logoCliptoSeed—Jan 2026
    Manus logoManusSeries C$75MJan 2026
    Aridge logoAridgeSeries A$200MJan 2026
    Xpeng Huitian logoXpeng HuitianSeries B$200MJan 2026
    OOpenchipSeries C—Jan 2026
    SSimplexity RoboticsUnknown$289MJan 2026
    QQuantXSeries B$130MJan 2026
    Meshy logoMeshySeries B$400MJan 2026
    QuantX Biosciences logoQuantX BiosciencesSeries B$85MJan 2026
    NewMed logoNewMedUnknown$100MJan 2026
    EEven RealitiesSeries B$150MJan 2026
    Gestala logoGestalaSeed—Jan 2026
    Tars logoTarsSeed$455MJan 2026
    D3 Bio logoD3 BioSeries C—Dec 2025
    PProviva TherapeuticsSeries A$30MDec 2025
    Page 1 of 13

    Top Co-Investors

    Last updated: 20 October 2026